Prostate Cancer

Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. April 25, 2025

Preservation of Neurovascular Bundles in High-risk Prostate Cancer Patients: Long-term Oncological Outcomes from Two High-volume Tertiary Centers. April 25, 2025

Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrence. April 25, 2025

Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI. April 25, 2025

The prognostic role of prostate MRI in prostate cancer patients. April 25, 2025

Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy. April 24, 2025

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial. April 24, 2025

Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study. April 24, 2025

Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes. April 24, 2025

Genetics of prostate cancer. April 24, 2025

A Retrospective Review of the Impact of Racial Disparities and Outcomes on Urinary Anastomotic Leak in Radical Prostatectomy in a National Surgical Registry. April 23, 2025

Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England. April 23, 2025

Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer. April 23, 2025

The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan). April 23, 2025

Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study. April 23, 2025

Targeting All Multiple Magnetic Resonance Imaging Prostate Lesions Does Not Enhance Cancer Detection: Insights from the YAU Prostate Cancer Group. April 22, 2025

Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients. April 22, 2025

Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer. April 22, 2025

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. April 22, 2025

Current and future directions in theranostics for neuroendocrine prostate cancer. April 22, 2025

Page 1 of 1473